Published in Surgery Litigation and Law Weekly, December 16th, 2005
According to recent research from the United States, "endoglin (CD105), a member of transforming growth factor beta 1 receptor complex, has been shown to be a more useful marker to identify tumor angiogenesis than panendothelial markers such as CD31. We investigated endoglin and VEGF expression as possible prognostic markers in esophageal adenocarcinoma."
"Surgical specimens from 75 patients with esophageal adenocarcinoma treated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly